VEEV - Veeva Systems Inc.
NYSE
->
Healthcare
->
Health Information Services
Pleasanton,
United States
Type: Equity
VEEV price evolution
VEEV
| (in millions $) | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1165.75 | |||
| Short term investments | $3719.32 | |||
| Net receivables | $301.29 | $404.15 | $401.09 | |
| Inventory | ||||
| Total current assets | $5447.16 | $5367.84 | $5244.95 | |
| Long term investments | ||||
| Property, plant & equipment | $116.02 | $99.83 | $102.63 | |
| Goodwill & intangible assets | $493.22 | |||
| Total noncurrent assets | $962.99 | |||
| Total investments | $3719.32 | |||
| Total assets | $6452.85 | $6330.84 | $6187.56 | |
| Current liabilities | ||||
| Accounts payable | $31.84 | $28.31 | $31.93 | |
| Deferred revenue | $956.38 | |||
| Short long term debt | $10.18 | |||
| Total current liabilities | $857 | $1070.44 | $1223.29 | |
| Long term debt | $43.91 | |||
| Total noncurrent liabilities | $75.7 | |||
| Total debt | $54.09 | |||
| Total liabilities | $951.45 | $1146.14 | $1298.18 | |
| Shareholders' equity | ||||
| Retained earnings | $3258.97 | $3073.16 | $2902.12 | |
| Other shareholder equity | -$6.46 | -$5.58 | -$30.65 | |
| Total shareholder equity | $5184.7 | |||
| (in millions $) | 31 Jan 2025 | 31 Dec 2023 | 3 Mar 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $703.49 | $886.47 | $730.5 | |
| Short term investments | $3324.27 | $2216.16 | $1238.06 | |
| Net receivables | $888.54 | $785.23 | $611.59 | |
| Inventory | ||||
| Total current assets | $5003.21 | $3969.31 | $2310.83 | |
| Long term investments | ||||
| Property, plant & equipment | $104.13 | $105.15 | $53.65 | |
| Goodwill & intangible assets | $502.89 | $522.35 | $541.82 | |
| Total noncurrent assets | $907.71 | $834.98 | $735.24 | |
| Total investments | $3324.27 | $2216.16 | $1238.06 | |
| Total assets | $5910.92 | $4804.3 | $3046.07 | |
| Current liabilities | ||||
| Accounts payable | $31.51 | $41.68 | $23.25 | |
| Deferred revenue | $1049.76 | $869.28 | $616.99 | |
| Short long term debt | $9.33 | $11.31 | $10.98 | |
| Total current liabilities | $1178.88 | $1006.8 | $715.95 | |
| Long term debt | $46.44 | $49.67 | $43.61 | |
| Total noncurrent liabilities | $87.21 | $81.24 | $63.8 | |
| Total debt | $55.77 | $60.98 | $54.59 | |
| Total liabilities | $1266.1 | $1088.04 | $779.75 | |
| Shareholders' equity | ||||
| Retained earnings | $2740.46 | $2214.75 | $1299.66 | |
| Other shareholder equity | -$10.64 | -$31.13 | $0.99 | |
| Total shareholder equity | $4644.82 | $3716.25 | $2911.64 | |
| (in millions $) | 30 Oct 2025 | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 3 Mar 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2363.67 | $2155.06 | $1465.07 | |
| Cost of revenue | $677.29 | $609.4 | $408.93 | |
| Gross Profit | $1686.38 | $1545.65 | $1056.14 | |
| Operating activities | ||||
| Research & development | $629.03 | $520.28 | $294.22 | |
| Selling, general & administrative | $628.02 | $566.29 | $384.13 | |
| Total operating expenses | $1257.05 | $1086.56 | $678.35 | |
| Operating income | $429.33 | $459.09 | $377.79 | |
| Income from continuing operations | ||||
| EBIT | $588.02 | $509.1 | $393.99 | |
| Income tax expense | $62.32 | $21.39 | $13.99 | |
| Interest expense | ||||
| Net income | ||||
| Net income | $525.71 | $487.71 | $380 | |
| Income (for common shares) | $525.71 | $487.71 | $380 | |
| (in millions $) | 1 Dec 2024 | 31 Aug 2024 | 30 May 2024 | 2 Mar 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$684.45 | -$386.22 | -$272.38 | -$1076.35 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $5.3 | -$7.66 | $3.83 | -$16.19 |
| Effect of exchange rate | -$1.35 | -$1.25 | -$1.26 | -$1.78 |
| Change in cash and equivalents | $340.02 | $461.26 | $493.71 | -$182.98 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $525.71 | $487.71 | $427.39 | $380 |
| Operating activities | ||||
| Depreciation | $44.32 | $41.32 | $38.89 | $39.8 |
| Business acquisitions & disposals | -$7.78 | |||
| Stock-based compensation | $393.73 | $351.91 | $234.64 | $185 |
| Total cash flows from operations | $911.34 | $780.47 | $764.46 | $551.25 |
| Investing activities | ||||
| Capital expenditures | -$26.2 | -$13.51 | -$14.21 | -$8.68 |
| Investments | -$1050.15 | -$994.17 | -$324.16 | -$324.95 |
| Total cash flows from investing | -$1076.35 | -$1007.68 | -$346.15 | -$333.63 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $62.69 | $43.65 | $51.54 | $34.86 |
| Net borrowings | -$0.38 | -$1.04 | ||
| Total cash flows from financing | -$16.19 | -$19.38 | -$4.14 | $33.82 |
| Effect of exchange rate | -$1.78 | -$4.99 | -$4.66 | $0.48 |
| Change in cash and equivalents | -$182.98 | -$251.57 | $409.51 | $251.91 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |